Baloney?The mindless pumpers keep tryiing to assert that bashers and mself are challenging the efficacy of PLI's deep drug pipeline. I have never done so as Barcy seems to imply. Nor can I recall anyone else doing so.
The real issue is not the pipeline. The real issue is whether management can deliver operating cash from somewhere and whether it will be hard money (diluting investment) or paid up equity (partnership).
Everything now depends upon this. More clinical trial results at this stage won't help this process. The companies negotiating with PLI have enough clinical information to make a decision. Further results are not likely change the efficacy picture. (what's better than 100%). I am skeptical about management delivering any where near to their plan due to their track record.
I do think partnership is possible right now.